Edgen Stock·Oct 14 2025, 07:51Back
Back
Eisai and Biogen's LEQEMBI IQLIK Recognized by TIME, Bolstering Alzheimer's Treatment Outlook
Edgen Stock·Oct 14 2025, 07:51
[1] LEQEMBI® IQLIK™ (lecanemab-irmb) Subcutaneous Autoinjector Named to TIME's "Best Inventions of 2025"[2] Leqembi Iqlik subcutaneous injection now available in US - Investing.com[3] LEQEMBI® IQLIK™(lecanemab-irmb) Subcutaneous Autoinjector Named to TIME's “Best Inventions of 2025” – Company Announcement - FT.com - Markets data
Features
Resources
© 2026 Finture Development Limited. All rights reserved